2019
DOI: 10.1016/j.ijpharm.2019.04.063
|View full text |Cite
|
Sign up to set email alerts
|

Photochemically stabilized formulation of dacarbazine with reduced production of algogenic photodegradants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…It was speculated that cysteine might protect photosensitive pharmaceuticals from photodegradation, due to its antioxidative activity. Other report showed that, in the case of dacarbazine, cysteine suppressed the generation of its photoproduct via its potential as a superoxide scavenger, but the residual rate of dacarbazine after photo-irradiation with cysteine was the same as that without it [ 16 ]. Tyrosine and tryptophan had no antioxidative potencies in the PAO test, indicating that they showed protective effects on NX photodegradation by other natures.…”
Section: Resultsmentioning
confidence: 99%
“…It was speculated that cysteine might protect photosensitive pharmaceuticals from photodegradation, due to its antioxidative activity. Other report showed that, in the case of dacarbazine, cysteine suppressed the generation of its photoproduct via its potential as a superoxide scavenger, but the residual rate of dacarbazine after photo-irradiation with cysteine was the same as that without it [ 16 ]. Tyrosine and tryptophan had no antioxidative potencies in the PAO test, indicating that they showed protective effects on NX photodegradation by other natures.…”
Section: Resultsmentioning
confidence: 99%
“…Both drugs are known to undergo fast photodegradations. Their kinetics have usually been fitted to 0th- or 1st-order models, irrespective of whether the light employed was mono- or polychromatic 1 – 3 , 9 , 43 48 . In aqueous solutions, their photodegradations produce species responsible of phototoxic effects 1 – 3 , 9 , 46 .…”
Section: Introductionmentioning
confidence: 99%
“…DTIC is an anticancer drug indicated for the treatment of metastatic malignant melanoma and soft tissue sarcoma, being also used in the treatment of early Hodgkin lymphoma. , Although it may be ionized, this API is commercialized in a neutral form as an intravenous formulation, exhibiting pH-dependent aqueous solubility and a pronounced photodegradation when exposed to light. , The main photodegradation product, 2-azahypoxanthine (2-AZA), is pharmacologically inactive and further responsible for some adverse reactions. , To reduce photodegradation, freshly prepared DTIC solutions protected from light must be intravenously administered as quickly as possible. , Recently, Uchida et al developed a photochemically stabilized formulation of DTIC using reactive oxygen species. The lack of scientific reports on this line reinforces the idea that the emergence of alternative and safe technologies to overcome DTIC issues remains highly demanded.…”
Section: Introductionmentioning
confidence: 99%
“… 20 , 21 To reduce photodegradation, freshly prepared DTIC solutions protected from light must be intravenously administered as quickly as possible. 22 , 23 Recently, Uchida et al 24 developed a photochemically stabilized formulation of DTIC using reactive oxygen species. The lack of scientific reports on this line reinforces the idea that the emergence of alternative and safe technologies to overcome DTIC issues remains highly demanded.…”
Section: Introductionmentioning
confidence: 99%